- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT02951793
Abuse and Addiction in ICU
Effect of Recent Alcohol, Smoking and Psychotropic Drug Use on Delirium in ICU
Investigators are seeking to determine the impact of recent alcohol, smoking or psychotropic drug use prior to intensive care unit (ICU) admission on incidence of delirium and sedation requirements.
Study design: A prospective observational study, in a medical ICU of a tertiary university hospital.
Methods: For all new ICU admissions, a 1-page questionnaire including Alcohol Use Disorders Identification Test (AUDIT-C), smoking history and prior medication use was given to the patient or closest family members.
Delirium was assessed by trained ICU nurses using Intensive Care Delirium Screening Checklist and Richmond Agitation-Sedation Scale.
Přehled studie
Postavení
Podmínky
Intervence / Léčba
Typ studie
Zápis (Očekávaný)
Kontakty a umístění
Studijní místa
-
-
-
Seoul, Korejská republika, 110744
- Seoul National University Hospital
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Metoda odběru vzorků
Studijní populace
Popis
Inclusion Criteria:
- Patients who are older than 18 years of age
- New patients admitted to medical ICU for the 1st time during their stay in hospital
Exclusion Criteria:
- Had history of stroke or other primary neurologic disease
- GCS ≤ 8 prior to ICU admission
- Transferred from other ICU (except for emergency ICU stay which is limited to less than 36 hours)
- Not registered within 24 hours after admission
- Refused to participate
- If comatous state persists
- Delirium assessment is not possible due to newly developed neurologic disease, such as cerebral infarction
- Medical ICU stay less than 24 hours
- Readmission to medical ICU
Studijní plán
Jak je studie koncipována?
Detaily designu
- Observační modely: Kohorta
- Časové perspektivy: Budoucí
Kohorty a intervence
Skupina / kohorta |
Intervence / Léčba |
|---|---|
|
AUDIT-C > 4
Significant alcohol use within 1 year prior to ICU admission (AUDIT-C>4)
|
Patients or their proxy/closest family member(s) undergo a comprehensive questionnaire including AUDIT-C about his/her alcohol behavior during last year and will be categorized into two groups: Those with AUDIT-C>4 versus AUDIT-C of 4 or below.
Ostatní jména:
|
|
AUDIT-C <=4
No significant alcohol use within 1 year prior to ICU admission (AUDIT-C: equal or less than 4)
|
Patients or their proxy/closest family member(s) undergo a comprehensive questionnaire including AUDIT-C about his/her alcohol behavior during last year and will be categorized into two groups: Those with AUDIT-C>4 versus AUDIT-C of 4 or below.
Ostatní jména:
|
|
Smoking history positive last year
Who smoke cigarette within 1-year prior to ICU admission
|
Patients or their proxy/closest family member(s) undergo a comprehensive questionnaire including smoking history during last year and will be categorized into two groups: Current smoker versus ex- or never smoker (we also recorded smoking pack-years to distinguish heavy smokers)
|
|
Smoking history negative last year
Who did not smoke cigarette within 1-year prior to ICU admission
|
Patients or their proxy/closest family member(s) undergo a comprehensive questionnaire including smoking history during last year and will be categorized into two groups: Current smoker versus ex- or never smoker (we also recorded smoking pack-years to distinguish heavy smokers)
|
|
Prior psychotropic medication use - yes
Who used psychotropic medication within 1-year prior to ICU admission
|
Patients or their proxy/closest family member(s) undergo a comprehensive questionnaire including psychotropic medication use prior admission to ICU and will be categorized into two groups: Those who use psychotropic medication versus those who do not use psychotropic medication.
|
|
Prior psychotropic medication use - no
Who did not use psychotropic medication within 1-year prior to ICU admission
|
Patients or their proxy/closest family member(s) undergo a comprehensive questionnaire including psychotropic medication use prior admission to ICU and will be categorized into two groups: Those who use psychotropic medication versus those who do not use psychotropic medication.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Časové okno |
|---|---|
|
Delirium during ICU stay
Časové okno: From date of ICU admission until the date of ICU discharge, whichever came first, assessed up to 3 months
|
From date of ICU admission until the date of ICU discharge, whichever came first, assessed up to 3 months
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
ICU length of stay
Časové okno: From date of ICU admission until the date of first documented discharge from ICU or death, whichever came first, assessed up to 3 months
|
From date of ICU admission until the date of first documented discharge from ICU or death, whichever came first, assessed up to 3 months
|
|
|
Mortality
Časové okno: From date of ICU admission until the date of death, assessed up to 3 months
|
Death in MICU
|
From date of ICU admission until the date of death, assessed up to 3 months
|
|
Maximal doses of dexmedetomidine
Časové okno: From date of ICU admission until the date of first documented discharge from ICU or death, whichever came first, assessed up to 3 months
|
From date of ICU admission until the date of first documented discharge from ICU or death, whichever came first, assessed up to 3 months
|
|
|
Cumulative dose of dexmedetomidine
Časové okno: From date of ICU admission until the date of first documented discharge from ICU or death, whichever came first, assessed up to 3 months
|
Cumulative dose of dexmedetomidine during the patient's MICU stay
|
From date of ICU admission until the date of first documented discharge from ICU or death, whichever came first, assessed up to 3 months
|
|
Cumulative dose of midazolam
Časové okno: From date of ICU admission until the date of first documented discharge from ICU or death, whichever came first, assessed up to 3 months
|
Cumulative dose of midazolam during the patient's MICU stay
|
From date of ICU admission until the date of first documented discharge from ICU or death, whichever came first, assessed up to 3 months
|
Spolupracovníci a vyšetřovatelé
Vyšetřovatelé
- Studijní židle: Jinwoo Lee, Professor, Seoul National University Hospital
- Vrchní vyšetřovatel: Jungsil Lee, M.D., Seoul National University Hospital
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia
Primární dokončení (Očekávaný)
Dokončení studie (Očekávaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- addiction742
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .